Moreover, IGF-1 released by the tumor microenvironment supported the development of drug resistance by sustaining the prompt regrowth of resistant tumor and by driving the remodeling of the tumor vasculature through activation of IGF-1R signaling on endothelial cells in a xenograft mouse model of melanoma (39). This evidence concerns the gene IGF1R and neoplasm.